111671 ⎘
ssRNA viruses positive-sense; Details; Togaviridae; Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Binary Self-Amplifying Nucleic Acid Platform and Uses Thereof
#2M1 VIRUS MUTANT AND USE THEREOF
#3COMPOSITIONS AND METHODS FOR INDUCING IMMUNE RESPONSES
#4ALPHAVIRUS T CELL EPITOPES, MEGAPOOLS AND USES THEREOF
#5VIRUS-LIKE VESICLES (VLVS) BASED VACCINES AND METHODS OF PREVENTING, AMELIORATING, AND/OR TREATING COVID-19 AND/OR HEPATOCELLULAR CARCINOMA (HCC)
#6RNA ENCODING VIRUS-LIKE PARTICLES AND USES THEREOF
#7FUSION ANTIGEN OF PORCINE GETAH VIRUS, KIT, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
#8VIRUS-LIKE PARTICLES AND METHODS OF USE
#9METHODS FOR CASCADE AMPLIFICATIONS OF THERAPEUTIC PAYLOADS (CATP) & COMPOSITIONS FOR CANCER IMMUNOTHERAPIES AND GENE THERAPY
#10SELF-AMPLIFYING mRNA VACCINE BASED ON Z7 GENOME
#11RNA VACCINE LIPID NANOPARTICLES
#12CORONAVIRUS VACCINE COMPOSITIONS AND METHODS
#13METHODS FOR GENERATING FUNCTIONAL SELF-REPLICATING RNA MOLECULES
#14ALPHAVIRUS REPLICON PARTICLE
#15METHOD OF PRODUCING PHARMACEUTICAL COMPOSITIONS COMPRISING IMMUNOGENIC CHIKUNGUNYA VIRUS CHIKV-DELTA5NSP3
#16CELL-TYPE SPECIFIC MEMBRANE FUSION PROTEINS
#17RNA CONSTRUCT
#18ENGINEERED VIRAL NUCLEIC ACIDS FOR DIRECTED EVOLUTION AND USES THEREOF
#19MODIFIED ALPHAVIRUSES WITH HETEROLOGOUS NONSTRUCTURAL PROTEINS
#20VERSATILE VIRUS-LIKE-VESICLES (VLV) PLATFORM FOR INFECTIOUS DISEASES AND CANCER IMMUNOTHERAPY APPLICATIONS
#21ATTENUATED ALPHAVIRUS
#22TEMPERATURE-CONTROLLABLE, RNA IMMUNOTHERAPEUTIC FOR CANCER
#23EFFICIENT VACCINE
#24MODIFIED EASTERN EQUINE ENCEPHALITIS VIRUSES, SELF-REPLICATING RNA CONSTRUCTS, AND USES THEREOF
#25METHODS AND COMPOSITIONS FOR QUADRIVALENT INFLUENZA VACCINE
#26TEMPERATURE-CONTROLLABLE, SELF-REPLICATING RNA VACCINES FOR VIRAL DISEASES
#27RABIES VIRUS VACCINE
#28Identification and Attenuation of the Immunosuppressive Domains in Fusion Proteins of Enveloped RNA Viruses
#29CIS-REPLICON CONSTRUCT
#30COMPOSITIONS AND METHODS FOR INDUCING IMMUNE RESPONSES
#31Coronavirus vaccine compositions and methods
#32MODULAR VIRAL GENOMES AND METHODS OF PRODUCING THE SAME
#33Virus-like particles and methods of use
#34Method of producing pharmaceutical compositions comprising immunogenic chikungunya virus CHIKV-delta5NSP3
#35COMPOSITIONS AND METHODS FOR INHIBITING VIRAL RECOGNITION SITES
#36COMPOSITIONS AND METHODS OF USE OF ONCOLYTIC VIRUS LIKE VESICLES
#37GENE TRANSFER SYSTEM
#38M1 VIRUS MUTANT AND USE THEREOF
#39Artificial alphavirus-derived RNA replicon expression systems
#40LIGAND-DIRECTED TARGETING VECTORS
#41Alphavirus nsP mutants as vaccines
#42Method of producing pharmaceutical compositions comprising immunogenic chikungunya virus CHIKV-Delta5NP3
#43RECOMBINANT VECTORS COMPRISING GENES FOR BINDING DOMAINS AND SECRETABLE PEPTIDES
#44Alphavirus replicon particle
#45ARTHROGENIC ALPHAVIRUS VACCINE
#46Virus-like particles and methods of use
#47Multimerizing Polypeptides Derived From Jelly Roll Fold Domain of Adenovirus Penton Base
#48Method of producing pharmaceutical compositions comprising immunogenic Chikungunya virus CHIKV-Delta5nsP3
#49Coronavirus vaccine compositions and methods
#50Compositions and methods for inducing immune responses
#51Identification and Attenuation of the Immunosuppressive Domains in Fusion Proteins of Enveloped RNA Viruses
#52Stable cell line secreting Chikungunya Virus (CHIKV) virus like particles (VLP) for vaccines
#53GENERATION OF HUMAN iPS CELLS BY A SYNTHETIC SELF-REPLICATIVE RNA
#54CHIKV RNA vaccines
#55Mayaro virus consensus antigens, DNA antibody constructs for use against Mayaro virus, and combinations thereof
#56Compositions and methods for alphavirus vaccination
#57ALPHAVIRUS-BASED REPLICONS FOR ADMINISTRATION OF BIOTHERAPEUTICS
#58Alphavirus NSP mutants as vaccines
#59Genome editing reagents and their use
#60Generation of human iPS cells by a synthetic self-replicative RNA
#61Packaging cell for making a pseudotyped lentivirus
#62Virus-like particles and methods of use
#63Arthrogenic alphavirus vaccine
#64Multigenome retroviral vector preparations and methods and systems for producing and using same
#65Infectious disease vaccines
#66Retrovirus packaging cell
#67CHIKV RNA vaccines
#68Zika RNA vaccines
#69Generation of human iPS cells by a synthetic self-replicative RNA
#70Methods of delivering a pseudotyped lentivirus
#71Nanocapsules carrying chikungunya-associated peptides
#72Virus Vectors Expressing Multiple Epitopes of Tumor Associated Antigens For Inducing Antitumor Immunity
#73Multigenome retroviral vector preparations and methods and systems for producing and using same
#74Virus like particle comprising PD-1 antigen or PD-1 ligand antigen
#75PRIME-BOOST REGIMENS WITH A TLR4 AGONIST ADJUVANT AND A LENTIVIRAL VECTOR
#76Virus-like particles and methods of use
#77Evolution of high-titer virus-like vesicles for vaccine applications
#78Engineered vesicles comprising antigenic peptides and the uses thereof as modulators of immune responses
#79Identification and attenuation of the immunosuppressive domains in fusion proteins of enveloped RNA viruses
#80Recombinant retrovirus pseudotyped with E2 alphavirus glycoprotein
#81Virus like particle comprising modified envelope protein E3
#82Chikungunya virus (CHIKV) or Venezuelan equine encephalitis virus (VEEV) virus-like particles comprising heterologous antigens inserted into the envelope protein
#83Infectious DNA vaccines against chikungunya virus
#84Recombinant measles virus expressing chikungunya virus polypeptides and their applications
#85Salmonid alphavirus and uses thereof
#86Method of stimulating an immune response using a pseudotyped lentivirus
#87Generation of human iPS cells by a synthetic self-replicative RNA
#88Isolated and purified strains of Chikungunya virus and polynucleotides and polypeptides sequences, diagnostic and immunogenical uses thereof
#89Virus like particle comprising PD-1 antigen or PD-1 ligand antigen
#90cDNA construct of Salmonidae alphavirus
#91Lipoparticles comprising proteins, methods of making, and using the same
#92Inactivated chikungunya viruses (CHIKV) comprising an E1-K211E mutation
#93Attenuated Chikungunya virus
#94Methods and compositions for pseudoinfectious alphaviruses
#95Targeting pseudotyped retroviral vectors
#96Salmonid alphavirus protein E2
#97Virus like particle composition
#98Infectious DNA vaccines against chikungunya virus
#99Vaccine for chikungunya virus infection
#100Attenuation of encephalitogenic alphavirus and uses thereof
#101Targeted gene delivery to dendritic cells
#102Expression vector encoding alphavirus replicase and the use thereof as immunological adjuvant
#103Fish vaccine
#104Flavivirus fusion inhibitors
#105Structural proteins of fish pancreatic disease virus and uses thereof
#106Consensus sequences of chikungunya viral proteins, nucleic acid molecules encoding the same, and compositions and methods for using the same
#107CDNA CONSTRUCT OF SALMONIDAE ALPHAVIRUS
#108RECOMBINANT ALPHAVIRUS-BASED VECTORS WITH REDUCED INHIBITION OF CELLULAR MACRO-MOLECULAR SYNTHESIS
#109Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
#110COMPOSITION AND METHOD FOR TREATING VIRAL INFECTION
#111Targeting pseudotyped retroviral vectors
#112Eukaryotic layered vector initiation systems
#113Defective sindbis viral vectors
#114Recombiant lentivirus comprising an E2 alphavirus glycoprotein that binds to DC-SIGN
#115Packaging cells for producing retrovirus pseudotyped with an E2 alphavirus glycoprotein
#116Novel Isolated And Purified Strains Of Chikungunya Virus And Polynucleotides And Polypetide Sequences, Diagnostic And Immunogenical Uses Thereof
#117Attenuation of encephalitogenic alphavirus and uses thereof
#118Chimeric alphavirus replicon particles
#119Chimeric alphavirus replicon particles
#120Flavivirus fusion inhibitors
#121Fish vaccine
#122TSG101-GAG INTERACTION AND USE THEREOF
#123cDNA construct of salmonidae alphavirus
#124DEFECTIVE SINDBIS VIRAL VECTORS
#125Structural proteins of fish pancreatic disease virus and uses thereof
#126Targeting Pseudotyped Retroviral Vectors
#127DEFECTIVE SINDBIS VIRAL VECTORS
#128Defective Sindbis viral vector comprising an anti-tumor gene
#129Recombinant alphavirus vectors and methods of using same
#130Membrane virus host range mutations and their uses as vaccine substrates
#131Targeted gene delivery for dendritic cell vaccination
#132Fusogenic, self-propagating blebs as immunogenic compositions
#133Defective sindbis viral vectors
#134Purified trimeric S protein as vaccine against severe acute respiratory syndrome virus infections
#135Chimeric alphavirus replicon particles
#136Methods for producing Marburg virus proteins
#137Virosome-like-particles
#138Targeting viruses using a modified sindbis glycoprotein
#139Alphavirus vectors having attentuated virion structural proteins
#140Chimeric vectors
#141Inducible alphaviral gene expression system
#142Optimized recognition site of the alphavirus non-structural protease for tag removal and specific processing of recombinant proteins
#143Flavivirus fusion inhibitors
#144Recombinant icosahedral virus like particle production in pseudomonads
#145Lipoparticles comprising proteins, methods of making, and using the same
#146Compositions and methods for the prevention and treatment of rabies virus infection
#147Alphavirus immunogens and methods of use